National Cancer Institute NCI Cancer Bulletin: A Trusted Source for Cancer Research News
November 16, 2010 • Volume 7 / Number 22


HHS Secretary Kathleen Sebelius announced proposed graphic warning labels that will appear on cigarette packs and in advertisements.HHS Releases New Tobacco Control Strategy for the Nation

The U.S. Department of Health and Human Services last week unveiled a new comprehensive tobacco control strategy that seeks to help smokers quit and stop others from starting to use tobacco. One high profile piece of the plan will result in bolder health warnings that must cover the upper half of the front and back of cigarette packages and at least 20 percent of tobacco product advertisements beginning in 2012. Read more > >


A 3D in vitro assay that mimics the formation of vasculature in vivo. (Image courtesy of Dr. Enrique Zudaire) What is this? Click on the image to find out.
An image of a tube formation assay taken with an epifluorescence microscope. The tube formation assay is a 3D in vitro assay that mimics the formation of vasculature in vivo. NCI’s Dr. Enrique Zudaire is using this assay to discover new drugs to block tumor angiogenesis and tumor growth. The nuclei of endothelial cells appear blue. In green are the endothelial cells, which have been genetically engineered to express a green fluorescent protein. The thinner areas are hollow tubes while the thicker areas are cell clusters. (Image courtesy of Dr. Enrique Zudaire)



  • Legislative Update

    • The 111th Congress Winds Down
  • Update

    • Boletín Showcases New Design and More Features
  • Notes

    • Biospecimens from SELECT and PCPT Now Available
    • Fraumeni Recognized for Achievements by American Cancer Society, American Italian Cancer Foundation
    • NCI Recognizes Clinical Investigators with Team Leadership Award
    • New Brochure on Biospecimens Available
    • New Issue of Cancer Health Disparities Newsletter Released
    • NCI Exhibit Booth Wins APHA Award

Selected articles from past issues of the NCI Cancer Bulletin are available in Spanish.

The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.

For more information about cancer, call 1-800-4-CANCER or visit

NCI Cancer Bulletin staff can be reached at

Next Section >